Cancer therapy using a self-replicating RNA vaccine

Keyphrases

• Cancer Therapy 100%
• Self-replicating RNA 100%
• RNA Vaccine 100%
• Model Antigen 40%
• RNA Virus Vector 40%
• Nucleic Acid Vaccine 40%
• Tumor 20%
• Immunogenicity 20%
• Dendritic Cells 20%
• Apoptotic Cell Death 20%
• Patients with Cancer 20%
• Intramuscular Injection 20%
• Transfected Cells 20%
• Immunogen 20%
• Clinical Efficacy 20%
• Cell Response 20%
• Immunization 20%
• Tumor Challenge 20%
• Cancer Vaccine 20%
• CD8+ T 20%
• Apoptotic Cells 20%
• Caspase-dependent 20%
• Non-infectious 20%
• Enhanced Efficacy 20%
• Semliki Forest Virus 20%
• Polyprotein 20%
• Self-replication 20%
• Antigen-specific Antibody 20%
• Efficacy in Vivo 20%
• RNA Replicase 20%
• Tumor Therapeutics 20%
• Therapeutic Immunization 20%
• DNA Vaccine 20%
• Enhanced Immunogenicity 20%

Immunology and Microbiology

• Immunogenicity 100%
• RNA Vaccine 100%
• RNA Vector 100%
• Ribonucleic Acid 100%
• Dendritic Cell 50%
• Programmed Cell Death 50%
• Caspase 50%
• Cytotoxic T-Cell 50%
• Tumor Vaccine 50%
• Semliki Forest Virus 50%
• RNA-dependent RNA Polymerase 50%
• DNA Immunization 50%
• In Vitro 50%